Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of -1075.09% is 16% above its 5-year average of -1278.14%, near the high end of its 5-year range (-10881.29%–86.19%).
8.34% below its 12-month average of -992.30%.
Reported quarterly EBITDA margin; no daily interpolation. Q2 FY2026 (2026-06-30): -872.76%.
EBITDA MARGIN
-1075.09%
EBITDA MARGIN AVG TTM
-992.30%
EBITDA MARGIN AVG 3Y
-1168.79%
EBITDA MARGIN AVG 5Y
-1278.14%
EBITDA MARGIN AVG 10Y
-1139.05%
EBITDA MARGIN AVG 15Y
N/A
EBITDA MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-8.34%
CURRENT VS 3Y AVG
+8.02%
CURRENT VS 5Y AVG
+15.89%
CURRENT VS 10Y AVG
+5.62%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
uniQure N.V.
Market Cap
$1.60B
EBITDA Margin
-1075.09%
TTM Avg
-992.30%
3Y Avg
-1168.79%
5Y Avg
-1278.14%
Market Cap
$1.61B
EBITDA Margin
-512.70%
TTM Avg
-388.17%
3Y Avg
-265.21%
5Y Avg
-263.30%
Market Cap
$1.61B
EBITDA Margin
-172.34%
TTM Avg
-3780.22%
3Y Avg
-1874.89%
5Y Avg
-1874.89%
Market Cap
$1.59B
EBITDA Margin
-164.52%
TTM Avg
-214.39%
3Y Avg
-473.06%
5Y Avg
-473.06%
Market Cap
$1.62B
EBITDA Margin
0.06%
TTM Avg
-4.29%
3Y Avg
-15.38%
5Y Avg
-22.40%
Market Cap
$1.63B
EBITDA Margin
19.54%
TTM Avg
15.33%
3Y Avg
15.07%
5Y Avg
12.91%
Market Cap
$1.57B
EBITDA Margin
-10.20%
TTM Avg
-140.78%
3Y Avg
-597.36%
5Y Avg
-597.36%
Market Cap
$1.54B
EBITDA Margin
-158.44%
TTM Avg
-796.42%
3Y Avg
-796.42%
5Y Avg
-1562.06%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| uniQure N.V. (QURE) | $1.60B | -1075.09% | -992.30% | -1168.79% | -1278.14% |
| Ocular Therapeutix, Inc. (OCUL)vs › | $1.61B | -512.70% | -388.17% | -265.21% | -263.30% |
| Septerna Inc (SEPN)vs › | $1.61B | -172.34% | -3780.22% | -1874.89% | -1874.89% |
| Kestra Medical Technologies, Ltd. (KMTS)vs › | $1.59B | -164.52% | -214.39% | -473.06% | -473.06% |
| Omnicell, Inc. (OMCL)vs › | $1.61B | 8.30% | 8.20% | 7.63% | 9.66% |
| Alphatec Holdings, Inc. (ATEC)vs › | $1.62B | 0.06% | -4.29% | -15.38% | -22.40% |
| ANI Pharmaceuticals, Inc. (ANIP)vs › | $1.63B | 19.54% | 15.33% | 15.07% | 12.91% |
| Stoke Therapeutics, Inc. (STOK)vs › | $1.57B | -10.20% | -140.78% | -597.36% | -597.36% |
| Syndax Pharmaceuticals, Inc. (SNDX)vs › | $1.54B | -158.44% | -796.42% | -796.42% | -1562.06% |
| Innoviva, Inc. (INVA)vs › | $1.54B | 47.98% | 50.86% | 52.39% | 67.36% |
Gross Margin
89.5%
EBITDA Margin
-1075.1%
Operating Margin
-1166.8%
Net Margin
-1350.7%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-06-30 | -872.76% |
| 2026-03-31 | -1159.83% |
| 2025-12-31 | -883.46% |
| 2025-09-30 | -1280.82% |
| 2025-06-30 | -764.63% |
| 2025-03-31 | -2221.06% |
| 2024-12-31 | -794.33% |
| 2024-09-30 | -1628.42% |
| 2024-06-30 | -371.56% |
| 2024-03-31 | -608.12% |
| 2023-12-31 | -860.52% |
| 2023-09-30 | -5634.68% |
| 2023-06-30 | -2579.93% |
| 2023-03-31 | -1345.45% |
| 2022-12-31 | 28.06% |
| 2022-09-30 | -3962.39% |
| 2022-06-30 | -10881.29% |
| 2022-03-31 | -2899.44% |
| 2021-12-31 | 6.79% |
| 2021-09-30 | -2172.95% |
| 2021-06-30 | 86.19% |
| 2021-03-31 | -9382.38% |
| 2020-12-31 | -17.52% |
| 2020-09-30 | -2215.82% |
| 2020-06-30 | -2373.68% |
| 2020-03-31 | -31471.15% |
| 2019-12-31 | -1190.17% |
| 2019-09-30 | -2830.88% |
| 2019-06-30 | -1118.96% |
| 2019-03-31 | -2283.01% |
| 2018-12-31 | -1382.96% |
| 2018-09-30 | -507.88% |
| 2018-06-30 | -640.72% |
| 2018-03-31 | -518.95% |
| 2017-12-31 | -818.03% |
| 2017-09-30 | -331.68% |
| 2017-06-30 | -348.95% |
| 2017-03-31 | -539.63% |
| 2016-12-31 | -114.54% |
| 2016-09-30 | -183.25% |
| 2016-06-30 | -443.67% |
| 2016-03-31 | -516.07% |
| 2015-12-31 | -333.55% |
| 2015-09-30 | -818.32% |
| 2015-06-30 | -1089.60% |
| 2015-03-31 | -705.51% |
| 2014-12-31 | -590.41% |
| 2014-09-30 | -735.99% |
| 2014-06-30 | -826.70% |
| 2014-03-31 | -637.01% |
| 2013-12-31 | -740.25% |
| 2013-09-30 | -405.08% |
| 2013-06-30 | -653.98% |
